The efficacy of mirtazapine in agitated patients with Alzheimer's disease: A 12-week open-label pilot study. - Wikidata - awgldk - TriplyDB

The efficacy of mirtazapine in agitated patients with Alzheimer's disease: A 12-week open-label pilot study.

The efficacy of mirtazapine in agitated patients with Alzheimer's disease: A 12-week open-label pilot study.

http://www.wikidata.org/entity/Q37062566

about

Antidepressants for agitation and psychosis in dementia Pharmacological management of behavioral symptoms associated with dementia Pharmacotherapy of neuropsychiatric symptoms of dementia Drug Therapy for Behavioral and Psychological Symptoms of Dementia A review of therapeutic uses of mirtazapine in psychiatric and medical conditions.Dementia-related agitation: a review of non-pharmacological interventions and analysis of risks and benefits of pharmacotherapy.Evidence and decision algorithm for the withdrawal of antipsychotic treatment in the elderly with dementia and neuropsychiatric symptoms.Mirtazapine does not improve sleep disorders in Alzheimer's disease: results from a double-blind, placebo-controlled pilot study.Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review.

P2860

Q24236550-C7C2CF78-EB24-4287-854C-4ECEFB492C45 Q28081955-E87F4FEC-9E79-4AF7-A2EB-F2726E07DE3A Q35229781-2DB4FC0E-4615-4A84-B934-DC72D19285FD Q36925888-C8430446-D228-466A-AA01-47C43B7723C2 Q37533880-38447289-D71B-4DFF-8631-0A081990B5EC Q46494191-0513388E-29BB-4E86-B725-60A034968B64 Q47737322-7F78AE8F-5F9D-4E8A-A955-C0719A1904B2 Q47894243-F9082452-B79D-4A92-82C1-AF8614E936B8 Q55000556-37179E18-D096-45C9-B5A4-7E79E1802CDB

P2860

The efficacy of mirtazapine in agitated patients with Alzheimer's disease: A 12-week open-label pilot study.

http://www.wikidata.org/entity/Q37062566

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The efficacy of mirtazapine in ...... 2-week open-label pilot study.

@en

The efficacy of mirtazapine in ...... 2-week open-label pilot study.

@nl

type

label

The efficacy of mirtazapine in ...... 2-week open-label pilot study.

@en

The efficacy of mirtazapine in ...... 2-week open-label pilot study.

@nl

prefLabel

The efficacy of mirtazapine in ...... 2-week open-label pilot study.

@en

The efficacy of mirtazapine in ...... 2-week open-label pilot study.

@nl

P1433

Q37062566-319B3A0B-97BA-4F0B-9828-114356F432C8

P1476

Q37062566-AD56E076-C394-4F79-BB72-D51F38F68D4E

P2093

Q37062566-2B5513DC-768C-4BFF-A301-DA64E432B5A0

Q37062566-8F720C25-8ECA-4854-821C-C5E51B79D263

P2860

Q37062566-23854E87-FA47-43D7-944C-BBA3DB835F01

Q37062566-253A392A-D533-459A-AD3E-67E392FE9A83

Q37062566-2DFB0132-3B96-4738-BD48-9DA5BA7338CE

Q37062566-31142816-B844-45A8-83EA-287494E37BEF

Q37062566-717EBAB1-CE8A-4043-9872-AA7E93216D35

Q37062566-7745C4EA-A0AC-4769-AB4B-DE371845724A

Q37062566-7863AFC7-A435-4BED-A6B8-5AD432861950

Q37062566-79AFA673-AB93-46EE-8E2D-63318A9FB95D

Q37062566-8071311B-9016-4F05-B5A8-FCBF08E4DF94

Q37062566-80943858-C0FC-4473-9E0B-09905D12D384

P304

Q37062566-FE0A410A-2310-455D-AF38-916F8709FCB5

P31

Q37062566-C3DBEC80-AC88-4F3E-998B-863AED63A8CE

P356

Q37062566-EE5797A9-95A0-4B29-BEE4-6C338E9437C5

P407

Q37062566-942CAE46-AADF-4A7C-A56C-41955F103095

P433

Q37062566-7459F19B-6669-4032-9117-A8F0B1C651D9

P478

Q37062566-AD3EB9DA-8E15-4D09-BDC7-A671ADB9985E

P577

Q37062566-D51775FD-72C0-4A22-A805-0E44F8A1A68C

P5875

Q37062566-175C98DD-C557-4805-AA7B-A3B37B5A372A

P698

Q37062566-159555CE-B114-4300-8BCD-1E91EAC8DDBA

P921

Q37062566-B7DFD0E6-2F23-4134-9F45-49EF4DBAC66E

P932

Q37062566-52DBEB59-B252-469E-BC75-75F402414C0B

P356

P1433

Neuropsychiatric Disease and Treatment

P1476

The efficacy of mirtazapine in ...... 2-week open-label pilot study.

@en

P2093

Isin Baral Kulaksizoglu

http://www.w3.org/2001/XMLSchema#string

Sibel Cakir

http://www.w3.org/2001/XMLSchema#string

P2860

Atypical antipsychotics for aggression and psychosis in Alzheimer's disease

Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.

Cognitive impairment in long-term benzodiazepine users.

Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.

Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.

Mirtazapine is associated with less anxiolytic use among elderly depressed patients in long-term care facilities.

Benzodiazepines of long and short elimination half-life and the risk of hip fracture.

An open pilot study of citalopram for behavioral disturbances of dementia. Plasma levels and real-time observations.

Assessment of agitation.

Agitated behaviors in the elderly. II. Preliminary results in the cognitively deteriorated.

P304

963-966

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/NDT.S3201

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23965547

http://www.w3.org/2001/XMLSchema#string

P698

19183787

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2626919

http://www.w3.org/2001/XMLSchema#string